Amyloid overexpression is known to disrupt endothelial function via reactive oxygen species (ROS), altered endothelial nitric oxide synthase (eNOS) activity, and impaired vascular regulation resulting from endothelial dysfunction rather than structural damage or apoptosis [64,72]. Here, NOS3 is linked to endothelial dysfunction.